We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesLENSAR Inc

LENSAR Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
4.605 USD 0.03 ( 0.55%)
Last update at 2026-11-12T15:43:00Z
VOLUME
19581
Market Cap
93.86M
P/E
38.20

Momentum Score

…

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.41
Low
4.61
High
52 Week Price Range
4.95
Low
12.94
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

LENSAR Inc designs and sells laser and imaging systems for cataract surgery, plus surgical planning software and related services. Long-term growth could be supported by ageing-driven procedure volumes, rising uptake of laser-assisted cataract techniques and expansion of its installed base and recurring service revenue, which may make the company attractive to investors seeking exposure to a focused ophthalmic-device niche.
Key risks include competition from larger device makers, slower clinical adoption or reimbursement headwinds, regulatory and execution risk during commercial scale-up, and constrained financial flexibility.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.58
Dividend Yield
-
Revenue TTM
60.26M
Revenue Per Share
4.96
Gross Profit TTM
29.13M
Debt / Equity
-0.11
ROE
35.73%
Net Debt
-10.24M
ROCE
-111.10%
Diluted EPS TTM
0.20

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -34.28M -31.40M -14.38M -19.91M -19.60M
Net income -34.28M -31.40M -14.38M -19.65M -19.65M
Selling general administrative 45.16M 26.49M 26.93M 27.17M 23.89M
Gross profit 27.12M 25.85M 21.11M 19.95M 17.83M
Reconciled depreciation 4.50M 3.93M 3.44M 3.41M 2.76M
Ebit -34.28M -6.94M -14.38M -20.18M -19.65M
Ebitda -29.78M -3.00M -10.87M -19.03M -18.36M
Depreciation and amortization 4.50M 3.93M 3.52M 1.15M 1.29M
Operating income -24.58M -10.66M -12.23M -20.18M -19.65M
Other operating expenses 83.01M 64.16M 54.39M 55.53M 54.11M
Interest expense - - - 0.26M 1.19M
Net interest income - - - - 0.00M
Income tax expense - - 3.35M -0.26M 0.05M
Total revenue 58.44M 53.49M 42.16M 35.36M 34.46M
Total operating expenses 51.70M 36.52M 33.34M 40.13M 37.48M
Cost of revenue 31.31M 27.64M 21.06M 15.40M 16.63M
Total other income expense net -9.70M -20.74M -2.15M 0.26M 0.05M
Net income from continuing ops -34.28M -31.40M -12.95M -19.91M -19.60M
Net income applicable to common shares - - - -19.91M -19.60M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 71.43M 66.30M 69.58M 55.84M 66.47M
Intangible assets 5.19M 6.11M 11.03M 12.12M 10.87M
Other current assets 0.90M 1.62M 2.37M 1.06M 1.70M
Total liab 97.45M 47.65M 22.41M 13.86M 11.59M
Total stockholder equity -26.02M 18.65M 47.18M 41.98M 54.88M
Other current liab 17.77M 6.81M 5.72M 4.70M 4.60M
Common stock 0.12M 0.12M 0.11M 0.11M 0.11M
Capital stock 0.12M 0.12M 0.11M 0.11M 0.11M
Retained earnings -177.57M -143.29M -111.89M -97.51M -77.59M
Other liab - - - 0.17M 0.07M
Other assets - - 0.00M 0.50M 3.34M
Cash 12.97M 16.26M 20.62M 14.67M 31.64M
Total current liabilities 40.57M 15.00M 11.63M 11.42M 8.71M
Current deferred revenue 3.07M 1.68M 1.35M 0.77M 0.90M
Net debt -10.24M -13.65M -18.31M -11.87M -28.83M
Short term debt 0.75M 0.52M 0.56M 0.53M 0.51M
Short long term debt total 2.73M 2.61M 2.31M 2.80M 2.80M
Other stockholder equity 151.43M 148.03M 145.20M 139.38M 132.36M
Property plant equipment - - - 9.51M 7.45M
Total current assets 46.77M 41.98M 46.44M 33.72M 44.81M
Long term investments - 0.00M 0.49M - -
Net tangible assets - - - 29.86M 44.01M
Short term investments 5.00M 6.19M 3.44M - -
Net receivables 6.38M 6.48M 4.32M 6.24M 4.99M
Inventory 21.52M 11.43M 15.69M 11.74M 6.49M
Accounts payable 18.98M 6.00M 4.01M 5.42M 2.69M
Accumulated other comprehensive income 0.00M 0.01M 0.00M - -
Non currrent assets other 18.96M 16.38M 0.07M 3.13M 3.34M
Non current assets total 24.66M 24.32M 23.14M 22.13M 21.65M
Capital lease obligations 2.73M 2.61M 2.31M 2.80M 3.31M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 1.37M -2.16M -0.25M -0.12M -0.35M
Change to liabilities - - - 2.73M 0.21M
Total cashflows from investing activities 1.28M -2.16M -4.16M -0.12M -0.35M
Total cash from financing activities 10.26M 0.08M 19.76M -1.99M 0.36M
Change to operating activities - - - 0.02M 0.07M
Net income -34.28M -31.40M -14.38M -19.91M -19.60M
Change in cash -3.29M -4.36M 5.95M -16.96M -8.96M
Begin period cash flow 16.26M 20.62M 14.67M 31.64M 40.60M
End period cash flow 12.97M 16.26M 20.62M 14.67M 31.64M
Total cash from operating activities -14.83M -2.27M -9.66M -14.86M -8.97M
Issuance of capital stock 0.09M 0.06M 13.88M - 0.00M
Depreciation 4.50M 3.93M 3.52M 3.41M 2.76M
Other cashflows from investing activities - - 0.00M - -
Dividends paid - - - - 0.00M
Change to inventory -13.90M -4.90M -7.46M -6.89M 2.33M
Change to account receivables 0.29M -2.10M 1.08M -1.44M -2.65M
Sale purchase of stock 0.59M 0.31M 0.33M 0.41M 0.36M
Other cashflows from financing activities 10.00M 0.02M 13.88M -2.40M -0.35M
Change to netincome - - - 7.23M 7.91M
Capital expenditures 0.08M 0.16M 0.24M 0.12M 0.35M
Change in working capital 1.10M -3.04M -7.78M -5.58M -0.04M
Stock based compensation 3.14M 2.67M 5.54M 6.61M 6.87M
Other non cash items 10.70M 25.58M 3.45M 0.62M 0.52M
Free cash flow -14.91M -2.43M -9.89M -14.97M -9.32M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
LNSR
LENSAR Inc		 0.03
0.55%		 4.61 38.20 - 1.56 6.44 1.41 -1.04
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

LENSAR Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

2800 Discovery Drive, Orlando, FL, United States, 32826

888 536 7271

https://www.lensar.com

150

Name Title Year Born
Mr. Nicholas T. Curtis CEO & Director 1956
Mr. Thomas R. Staab II, CPA CFO & Sec. 1968
Mr. Alan B. Connaughton Chief Operating Officer 1972
Ms. Kendra W. Wong Principal Accounting Officer 1980
Mr. Nicholas T. Curtis President, CEO & Director 1957
Mr. Thomas R. Staab II, CPA CFO & Secretary 1968
Mr. Nicholas T. Curtis President, CEO & Director 1956
Mr. Michael A. Rossi Interim CFO & Principal Financial Officer and Secretary 1974

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…